@article{522efa00978f432b88027cdc115a60c7,
title = "Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study",
keywords = "clinical trial, methotrexate, rituximab, secondary CNS lymphoma, transplantation, treatment, NON-HODGKINS-LYMPHOMA, PRIMARY CNS LYMPHOMA, MABTHERA INTERNATIONAL TRIAL, CHEMOTHERAPY PLUS RITUXIMAB, STUDY-GROUP DSHNHL, AGGRESSIVE LYMPHOMA, ELDERLY-PATIENTS, MARROW-TRANSPLANTATION, INTRAOCULAR LYMPHOMA, RESPONSE CRITERIA",
author = "Doorduijn, {Jeanette K.} and {van Imhoff}, {Gustaaf W.} and {van der Holt}, Bronno and Schouten, {Harry C.} and Schaafsma, {Martijn R.} and MacKenzie, {Marius A.} and Baars, {Joke W.} and Kersten, {Marie Jose} and Lugtenburg, {Pieternella J.} and {van den Bent}, {Martin J.} and Enting, {Roelien H.} and Spoelstra, {Fokje M.} and Philip Poortmans and Bromberg, {Jacoline E. C.}",
year = "2017",
month = dec,
doi = "10.1002/hon.2342",
language = "English",
volume = "35",
pages = "497--503",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "Wiley",
number = "4",
}